Skip to main content
MedicHelpLine
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALStandard

PIMOZIDE

PIMOZIDE

Standard Dose
2MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Prescription
Summary

Approval overview PIMOZIDE is listed in Drugs@FDA under application 204521 (ANDA).

Marketing status: Prescription Active ingredient PIMOZIDE Form and strength TABLET;ORAL - 2MG Sponsor PH HEALTH Submission history Latest submission status date: 2015-09-28 00:00:00.

Structured Monograph

Clinical summary

Approval overview PIMOZIDE is listed in Drugs@FDA under application 204521 (ANDA). Marketing status: Prescription Active ingredient PIMOZIDE Form and strength TABLET;ORAL - 2MG Sponsor PH HEALTH Submission history Latest submission status date: 2015-09-28 00:00:00. Submission type: ORIG.

Monitoring

  • Marketing status: Prescription

Interaction Notes

  • No interaction notes stored yet.
PIMOZIDE (PIMOZIDE) | Drug Monograph | MedicHelpline